Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival
The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an...
Gespeichert in:
Veröffentlicht in: | Clinical gastroenterology and hepatology 2024-12, Vol.22 (12), p.2529-2531.e7 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2531.e7 |
---|---|
container_issue | 12 |
container_start_page | 2529 |
container_title | Clinical gastroenterology and hepatology |
container_volume | 22 |
creator | Kang, James H.-E. Jensen, Christopher D. Merchant, Sophie A. Lee, Jeffrey K. |
description | The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7 |
doi_str_mv | 10.1016/j.cgh.2024.05.014 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3060384062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542356524004889</els_id><sourcerecordid>3060384062</sourcerecordid><originalsourceid>FETCH-LOGICAL-c235t-9703cc640ddb4b1352bef5ed39bb894503084183846da5ae2abfe7d40b8a5e6a3</originalsourceid><addsrcrecordid>eNp9kEtr3DAUhUVJaR7tD-imaJmNnauXH3SVmrYJDLTQdC1k6bqjwbamkj2Qf18NM-kyq3s4nHPgfoR8ZFAyYNXdrrR_tiUHLktQJTD5hlwxJXlR10xenLVQlbok1yntAHgr2_oduRRN3XBWyyuy3aBx9MlPSM3s6OM0hbiY8eR88SZhyube2IUuW6SdGe06msWHmYaB_gxpKWwYwxySDftn2mUd0R4XOjNbjPTXGg_-YMb35O1gxoQfzveG_P729al7KDY_vj9295vCcqGWoq1BWFtJcK6XPROK9zgodKLt-6aVCgQ0kjWikZUzyiA3_YC1k9A3RmFlxA25Pe3uY_i7Ylr05JPFcTQzhjVpARXkNlQ8R9kpamNIKeKg99FPJj5rBvoIWO90BqyPgDUonQHnzqfz_NpP6P43XojmwOdTAPOTB49RJ-sxo3D-CEa74F-Z_wejBYve</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3060384062</pqid></control><display><type>article</type><title>Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kang, James H.-E. ; Jensen, Christopher D. ; Merchant, Sophie A. ; Lee, Jeffrey K.</creator><creatorcontrib>Kang, James H.-E. ; Jensen, Christopher D. ; Merchant, Sophie A. ; Lee, Jeffrey K.</creatorcontrib><description>The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7</description><identifier>ISSN: 1542-3565</identifier><identifier>ISSN: 1542-7714</identifier><identifier>EISSN: 1542-7714</identifier><identifier>DOI: 10.1016/j.cgh.2024.05.014</identifier><identifier>PMID: 38782174</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Aged, 80 and over ; California - epidemiology ; Colonoscopy - statistics & numerical data ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - mortality ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Survival Analysis ; Time Factors</subject><ispartof>Clinical gastroenterology and hepatology, 2024-12, Vol.22 (12), p.2529-2531.e7</ispartof><rights>2024 AGA Institute</rights><rights>Copyright © 2024 AGA Institute. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c235t-9703cc640ddb4b1352bef5ed39bb894503084183846da5ae2abfe7d40b8a5e6a3</cites><orcidid>0000-0001-9635-7343</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.cgh.2024.05.014$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38782174$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kang, James H.-E.</creatorcontrib><creatorcontrib>Jensen, Christopher D.</creatorcontrib><creatorcontrib>Merchant, Sophie A.</creatorcontrib><creatorcontrib>Lee, Jeffrey K.</creatorcontrib><title>Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival</title><title>Clinical gastroenterology and hepatology</title><addtitle>Clin Gastroenterol Hepatol</addtitle><description>The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>California - epidemiology</subject><subject>Colonoscopy - statistics & numerical data</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - mortality</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Retrospective Studies</subject><subject>Survival Analysis</subject><subject>Time Factors</subject><issn>1542-3565</issn><issn>1542-7714</issn><issn>1542-7714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtr3DAUhUVJaR7tD-imaJmNnauXH3SVmrYJDLTQdC1k6bqjwbamkj2Qf18NM-kyq3s4nHPgfoR8ZFAyYNXdrrR_tiUHLktQJTD5hlwxJXlR10xenLVQlbok1yntAHgr2_oduRRN3XBWyyuy3aBx9MlPSM3s6OM0hbiY8eR88SZhyube2IUuW6SdGe06msWHmYaB_gxpKWwYwxySDftn2mUd0R4XOjNbjPTXGg_-YMb35O1gxoQfzveG_P729al7KDY_vj9295vCcqGWoq1BWFtJcK6XPROK9zgodKLt-6aVCgQ0kjWikZUzyiA3_YC1k9A3RmFlxA25Pe3uY_i7Ylr05JPFcTQzhjVpARXkNlQ8R9kpamNIKeKg99FPJj5rBvoIWO90BqyPgDUonQHnzqfz_NpP6P43XojmwOdTAPOTB49RJ-sxo3D-CEa74F-Z_wejBYve</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Kang, James H.-E.</creator><creator>Jensen, Christopher D.</creator><creator>Merchant, Sophie A.</creator><creator>Lee, Jeffrey K.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9635-7343</orcidid></search><sort><creationdate>202412</creationdate><title>Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival</title><author>Kang, James H.-E. ; Jensen, Christopher D. ; Merchant, Sophie A. ; Lee, Jeffrey K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c235t-9703cc640ddb4b1352bef5ed39bb894503084183846da5ae2abfe7d40b8a5e6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>California - epidemiology</topic><topic>Colonoscopy - statistics & numerical data</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - mortality</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Retrospective Studies</topic><topic>Survival Analysis</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kang, James H.-E.</creatorcontrib><creatorcontrib>Jensen, Christopher D.</creatorcontrib><creatorcontrib>Merchant, Sophie A.</creatorcontrib><creatorcontrib>Lee, Jeffrey K.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical gastroenterology and hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kang, James H.-E.</au><au>Jensen, Christopher D.</au><au>Merchant, Sophie A.</au><au>Lee, Jeffrey K.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival</atitle><jtitle>Clinical gastroenterology and hepatology</jtitle><addtitle>Clin Gastroenterol Hepatol</addtitle><date>2024-12</date><risdate>2024</risdate><volume>22</volume><issue>12</issue><spage>2529</spage><epage>2531.e7</epage><pages>2529-2531.e7</pages><issn>1542-3565</issn><issn>1542-7714</issn><eissn>1542-7714</eissn><abstract>The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs).1 PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy.2 PCCRC prognosis is unclear, with outcomes reported as comparable,3 superior,4 or inferior5,6 to those of dCRC. Because WEO terminology defines cases relative to the index colonoscopy, conventional survival analyses of PCCRC are susceptible to lead time and immortal time biases. We evaluated the influence of these biases on mortality in a population-based retrospective cohort of 10,938 dCRCs (93.8%) and 717 PCCRCs (6.2%). This study was set within Kaiser Permanente Northern California (KPNC), a large integrated health system, whose members are similar in demographic and socioeconomic characteristics to the Northern California region.7</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38782174</pmid><doi>10.1016/j.cgh.2024.05.014</doi><orcidid>https://orcid.org/0000-0001-9635-7343</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1542-3565 |
ispartof | Clinical gastroenterology and hepatology, 2024-12, Vol.22 (12), p.2529-2531.e7 |
issn | 1542-3565 1542-7714 1542-7714 |
language | eng |
recordid | cdi_proquest_miscellaneous_3060384062 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | Adult Aged Aged, 80 and over California - epidemiology Colonoscopy - statistics & numerical data Colorectal Neoplasms - diagnosis Colorectal Neoplasms - mortality Female Humans Male Middle Aged Retrospective Studies Survival Analysis Time Factors |
title | Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T18%3A33%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lead%20Time%20and%20Immortal%20Time%20Biases%20Impact%20the%20Calculation%20of%20Post-colonoscopy%20Colorectal%20Cancer%20Survival&rft.jtitle=Clinical%20gastroenterology%20and%20hepatology&rft.au=Kang,%20James%20H.-E.&rft.date=2024-12&rft.volume=22&rft.issue=12&rft.spage=2529&rft.epage=2531.e7&rft.pages=2529-2531.e7&rft.issn=1542-3565&rft.eissn=1542-7714&rft_id=info:doi/10.1016/j.cgh.2024.05.014&rft_dat=%3Cproquest_cross%3E3060384062%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3060384062&rft_id=info:pmid/38782174&rft_els_id=S1542356524004889&rfr_iscdi=true |